Global Non-Hodgkin Lymphoma Therapeutics Market Report By Cancer Type (Glioma, Meningioma, Pituitary Adenoma, Schwannomas And Medulloblastoma), By Therapeutics (Radiation Therapy, Chemotherapy And Targeted Therapy) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2017-2024
ID:VMR11210175
October 2018
Report Formats:

As per this study the Global Non-Hodgkin Lymphoma Therapeutics Market was valued USD 4.8 BN (by revenue) in 2017 and is anticipated to reach USD 7.7 BN by 2024 with a CAGR of 7%.
 
Non-hodgkin lymphoma is the type of blood cancer that affects the lymphatic system. The infected cells lose their ability to fight infection, thus the make body vulnerable to other infections. Radiation therapy, chemotherapy and others are the therapeutics used to treat blood cancers.
 
Objectives of the Study:

  • Define and measure the global non-hodgkin lymphoma therapeutics market
  • Revenue forecast of the global non-hodgkin lymphoma therapeutics market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
 
Market Dynamics
 
Rising prevalence of cancer across the globe and increasing demand of monoclonal antibodies and novel therapies to treat cancer is driving the market growth. Increased R&D for development of novel therapies is further boosting the market growth. However, high cost of drugs is likely to restrain the market growth in following years.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of non-hodgkin lymphoma therapeutics.
 
Market Segmentation
 
The broad non-hodgkin lymphoma therapeutics market has been sub-grouped into cancer type and therapeutics. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Cancer Type
  • Glioma
  • Meningioma
  • Pituitary Adenoma
  • Schwannomas
  • Medulloblastoma
 
By Therapeutics
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for non-hodgkin lymphoma therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Non-Hodgkin Lymphoma Therapeutics Market By Revenue (USD MN)
 
Europe Non-Hodgkin Lymphoma Therapeutics Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Bayer AG, Bristol Myers Squibb Co., F. Hoffman La-Roche Ltd., GlaxoSmithKline plc, Merck, Novartis, Pfizer, and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1. INTRODUCTION

  • Introduction To Non-Hodgkin Lymphoma Therapeutics
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Non-Hodgkin Lymphoma Therapeutics Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY CANCER TYPE
  • Market In Glioma
  • Market In Meningioma
  • Market In Pituitary Adenoma
  • Market In Schwannomas
  • Market In Medulloblastoma
 
5. NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS
  • Market In Radiation Therapy
  • Market In Chemotherapy
  • Market In Targeted Therapy
 
6. NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE NON-HODGKIN LYMPHOMA THERAPEUTICS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE NON-HODGKIN LYMPHOMA THERAPEUTICS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Bayer AG
  • Bristol Myers Squibb Co.
  • F. Hoffman La-Roche Ltd.
  • GlaxoSmithKline plc
  • Merck
  • Novartis
  • Pfizer
  • Others
 
* Tentative TOC
 
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Non-Hodgkin Lymphoma Therapeutics
Table 2.  Global Non-Hodgkin Lymphoma Therapeutics Market By Cancer Type
Table 3.  Global Non-Hodgkin Lymphoma Therapeutics Market By Therapeutics
Table 4.  Global Non-Hodgkin Lymphoma Therapeutics Market By Geography
Table 5.  North America Non-Hodgkin Lymphoma Therapeutics Market
Table 6.  Europe Non-Hodgkin Lymphoma Therapeutics Market
Table 7.  Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market
Table 8.  Latin America Non-Hodgkin Lymphoma Therapeutics Market
Table 9.  Middle East And Africa Non-Hodgkin Lymphoma Therapeutics Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Non-Hodgkin Lymphoma Therapeutics Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Non-Hodgkin Lymphoma Therapeutics
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Non-Hodgkin Lymphoma Therapeutics Market By Cancer Type
Fig. 8.     Global Non-Hodgkin Lymphoma Therapeutics Market By Therapeutics
Fig. 9.     Global Non-Hodgkin Lymphoma Therapeutics Market By Geography
Fig. 10.   North America Non-Hodgkin Lymphoma Therapeutics Market
Fig. 11.   Europe Non-Hodgkin Lymphoma Therapeutics Market
Fig. 12.   Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market
Fig. 13.   Latin America Non-Hodgkin Lymphoma Therapeutics Market
Fig. 14.   Middle East And Africa Non-Hodgkin Lymphoma Therapeutics Market
Fig. 15.   Market Share Of Non-Hodgkin Lymphoma Therapeutics Companies
Fig. 16.   Recent Developments In Non-Hodgkin Lymphoma Therapeutics Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials